Agios Pharmaceuticals Inc


Agios Pharmaceuticals Inc’s Shares are Fully Valued at Current Levels: Oppenheimer

In a research report released April 20, Oppenheimer analyst Ling Wang initiated coverage on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), while no price target was …

UPDATE: MLV Reiterates Buy on Agios Pharmaceuticals Inc on Back of Orphan Designation

In a research report issued today, MLV analyst Arlinda Lee maintained a Buy rating on Agios Pharmaceuticals Inc (NASDAQ:AGIO) with a price target …

Agios Is A Must Own Stock, But Not At Current Valuation, Says Roth Capital

Roth Capital’s healthcare analyst Debjit Chattopadhyay came out with a few comments on Agios Pharmaceuticals Inc (NASDAQ:AGIO), after the company reported a worse than expected fourth quarter results …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts